Global Bacterial Vaginosis (BV) Treatment Market Size, Share & Trends Analysis Report, By Treatment (Antibiotics, Vaginal Creams & Gels, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies), Forecast (2022-2028)

The global bacterial vaginosis (BV) treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). It is a vaginal disorder that produces vaginal discharge on account of an overgrowth of certain kinds of bacteria in the vagina. The market growth is majorly attributable to the growing prevalence of BV among women across the globe. For instance, as per the American Sexual Health Association 2019, BV is a common gynecologic infection, which affects nearly 29% of women in the US. Hence, the rising incidence of BV is leading to an upsurge in R&D for its treatment by private manufacturers and research organizations. BV is a global concern due to the increased risk of acquisition of sexually transmitted infections.

Key players of the market include Allergan plc (AbbVie Inc.), Pfizer Inc., and Star pharma Holdings Ltd., among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on. For instance, in August 2020, Daré Bioscience, Inc., announced the publication of a proof-of-concept study of DARE-BV1 in Clinical and Experimental Obstetrics & Gynecology, an international journal focused on the publication of high-quality scientific research related to obstetrics and gynecology and women’s health. DARE-BV1 is a novel thermosetting bio-adhesive hydrogel containing clindamycin phosphate 2% that is being evaluated as a one-time vaginally administered treatment for bacterial vaginosis (BV).

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Treatment
• By Distribution Channel

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Allergan plc (AbbVie Inc.), Pfizer Inc., and Starpharma Holdings Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bacterial Vaginosis Market Report by Segment

By Treatment

• Antibiotics
• Vaginal Creams & Gels
• Others

By Distribution Channel

• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies

Global Bacterial Vaginosis Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa